ALFA Finder| Management target | EBITDA FY30 |
|---|
| Revenue growth | 21% YoY |
|---|---|
| Margins | EBITDA margin at 33%; target 30% CAGR for EBITDA |
| Order book | Key wins in California, Musculoskeletal, Advocate Health |
| Demand visibility | Strong; US healthcare expenditure US$5tn |
| Management confidence | High regarding margin expansion |
Growth
Revenue grew 21% YoY in INR (12% in USD); PAT rose 27.8% YoY to INR 1,937 mn.
Outlook
Targeting INR 30,000 mn EBITDA by FY30. Focused on sustaining expansion without significant equity dilution.
Risks
One-time acquisition costs and reduced currency gains impacted QoQ margins and PAT.
Last quarter's promises, checked
Delivered
- Guided 12% outsourced TAM growth → delivered 21% YoY revenue growth (= BEAT)
- Guided 500-600 client range → delivered 600+ clients (= BEAT)
- Guided margin expansion via AQuity integration → delivered 33% EBITDA margin (= BEAT)
Partly delivered
- Guided debt reduction from INR 8,500 mn peak → delivered INR 2,654 mn net debt (= PARTIAL)
Investor Presentation filed with NSE, NSE: IKS. Summary written with AI assistance from the document.
Inventurus Knowledge Solutions Ltd: key numbers
- Share price
- ₹1,660.20
- Market cap
- ₹28,485 Cr
- Revenue (annual)
- ₹3,192 Cr
- Net profit (annual)
- ₹721.5 Cr
- P/E (TTM)
- 35.6×Sector 54.5×
- Promoter holding
- 63.72%+0.00% QoQ
- FII holding
- 8.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Inventurus Knowledge Solutions Ltd
All →Inventurus Knowledge Solutions Acquisition Worth ₹4.65 Cr
Inventurus Knowledge Solutions' US subsidiary acquired 100% of Turbo Health Holdings, LLC for USD 500,000. The deal, worth ₹4.65 Crore, expands market reach in healthcare technology.
- Value
- ₹4.65 Cr
Inventurus Knowledge Solutions Earnings Call Transcript: Key Takeaways
Revenue ₹1,592 Cr (+104% YoY, mostly TrueBridge consolidation) and EBITDA ₹442 Cr (~28%). Legacy IKS grew ~13% in USD. TrueBridge is flat for FY27, and management gives no growth guidance.
Inventurus Knowledge Solutions Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 15,925 mn (+103.9% YoY) with TruBridge consolidated for 82 days. Reported EBITDA margin 27.7%; PAT INR 2,176 mn (+20.4% YoY); adjusted PAT INR 2,734 mn.
Inventurus Knowledge Solutions Results Update
IKS Health reported strong Q2 FY27 revenue and EBITDA growth year-on-year, with TruBridge integration adding scale. The release also highlighted new US healthcare customer wins.
Inventurus Knowledge Solutions Q2 FY27 Results: Net Profit ₹213.4 Cr, Up 18.1% YoY
Inventurus Knowledge Solutions Ltd reported revenue from operations of ₹1,592 Cr (+103.9% YoY) and net profit of ₹213.4 Cr (+18.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹213.4 Cr · +18.1% YoY
Inventurus Knowledge Solutions Board Meeting Date
Inventurus Knowledge Solutions will hold a board meeting on 05 November 2026 to consider September 2026 results. This advance notice reports no approved results yet.